Posts

Showing posts from May, 2021

AstraZenica ascendant and QMU no more

After our initial return to Pfizer we have switched once again to AstraZenica. This has roughly corresponded with when we made the switch in March so that we can continue to provide second doses to the same cohort of people. As we power through May we are now regularly seeing 700 cars each day and delivering first and second doses on a ratio of about 1:5. As a result I have increased my hours for the next month or so from 16 to 24 hours a week. It all feels very well paced, useful and satisfying. We mostly see people in their fifties and upwards coming for their second jag and some younger people for their first. However AstraZenica is not now offered to anyone under 30 and anyone under 40 can choose to have it or opt to be sent elsewhere for an alternative. Quite a few thirtysomethings seem happy enough to opt for the AstraZenica once they have had a chat with a vaccinator. On another, sadder note the drive through service at QMU is ending next month. We will deliver our final ...

Community Practitioner

Image
I'm told this article is due to appear in the current issue of Community Practitioner ( https://www.communitypractitioner.co.uk/ ). I'm not able to verify this as access to the journal is via membership access. It's based on a few of my earlier blog entries.  

The Second Pfizers of May

Full on with second doses now. And May is not living up to its springtime billing so far! It has been very cold and wet at times. On my first day administering second jags I noticed that all of the clients were from a particular date in February and that the following day they would correspond with my first shift as a vaccinator. I wondered if I would meet anyone to whom I had given a first jab. The third client tuned out to one such person as indeed did a few others over the course on my second shift. It was very nice to meet up with people a second time. We are now picking up a clearer picture of reactions to first jags and it seems pretty minimal with the Pfizer. Of the many dozen second doses I have now given, the vast majority reported little or no side effects with only a couple reporting feelings of being unwell for a few days. The numbers are also back up to better levels than in April with figures above 500 most days. This certainly helps the shifts to rattle along if y...